These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 3148816)
1. Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum. Parsons NJ; Patel PV; Tan EL; Andrade JR; Nairn CA; Goldner M; Cole JA; Smith H Microb Pathog; 1988 Oct; 5(4):303-9. PubMed ID: 3148816 [TBL] [Abstract][Full Text] [Related]
2. Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid. Parsons NJ; Andrade JR; Patel PV; Cole JA; Smith H Microb Pathog; 1989 Jul; 7(1):63-72. PubMed ID: 2509853 [TBL] [Abstract][Full Text] [Related]
3. Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum. Nairn CA; Cole JA; Patel PV; Parsons NJ; Fox JE; Smith H J Gen Microbiol; 1988 Dec; 134(12):3295-306. PubMed ID: 3151997 [TBL] [Abstract][Full Text] [Related]
5. A surface polysaccharide forms when gonococci are converted to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid. Fox AJ; Curry A; Rowland PL; Lancaster S; Jones DM; Parsons NJ; Cole JA; Smith H FEMS Microbiol Lett; 1990 Jan; 54(1-3):75-80. PubMed ID: 2108900 [TBL] [Abstract][Full Text] [Related]
6. A high Mr factor in human blood which confers serum resistance on gonococci: some properties and synergism with CMP-NANA. Constantinidou C; Beadle D; Zhou XH; Parsons NJ; Sammons CC; Cole JA; Smith H Microb Pathog; 1992 Jun; 12(6):421-32. PubMed ID: 1522797 [TBL] [Abstract][Full Text] [Related]
7. Identification by mass spectrometry of CMP-NANA in diffusible material released from high M(r) blood cell fractions that confers serum resistance on gonococci. Parsons NJ; Ashton PR; Constantinidou C; Cole JA; Smith H Microb Pathog; 1993 Apr; 14(4):329-35. PubMed ID: 8326856 [TBL] [Abstract][Full Text] [Related]
8. Interaction of pathogenic Neisseria with host defenses. What happens in vivo? Rest RF; Liu J; Talukdar R; Frangipane JV; Simon D Ann N Y Acad Sci; 1994 Aug; 730():182-96. PubMed ID: 8080170 [TBL] [Abstract][Full Text] [Related]
9. Neisseria gonorrhoeae LPS variation, serum resistance and its induction by cytidine 5'-monophospho-N-acetylneuraminic acid. Demarco de Hormaeche R; van Crevel R; Hormaeche CE Microb Pathog; 1991 Apr; 10(4):323-32. PubMed ID: 1716719 [TBL] [Abstract][Full Text] [Related]
10. Sialylation of lipopolysaccharide by CMP-NANA in viable gonococci is enhanced by low Mr material released from blood cell extracts but not by some UDP sugars. Parsons NJ; Constantinidou C; Cole JA; Smith H Microb Pathog; 1994 Jun; 16(6):413-21. PubMed ID: 7830528 [TBL] [Abstract][Full Text] [Related]
11. The sialylation of gonococcal lipopolysaccharide by host factors: a major impact on pathogenicity. Smith H; Cole JA; Parsons NJ FEMS Microbiol Lett; 1992 Dec; 100(1-3):287-92. PubMed ID: 1478464 [TBL] [Abstract][Full Text] [Related]
12. The surface structure seen on gonococci after treatment with CMP-NANA is due to sialylation of surface lipopolysaccharide previously described as a 'capsule'. Fox AJ; Curry A; Jones DM; Demarco de Hormaeche R; Parsons NJ; Cole JA; Smith H Microb Pathog; 1991 Sep; 11(3):199-210. PubMed ID: 1724790 [TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide alteration is associated with induced resistance of Neisseria gonorrhoeae to killing by human serum. Tan EL; Patel PV; Parsons NJ; Martin PM; Smith H J Gen Microbiol; 1986 May; 132(5):1407-13. PubMed ID: 3095492 [TBL] [Abstract][Full Text] [Related]
14. Kinetics of conversion of Neisseria gonorrhoeae to resistance to complement by cytidine 5'-monophospho-N-acetyl neuraminic acid. Emond JP; Dublanchet A; Goldner M Antonie Van Leeuwenhoek; 1995; 67(3):281-8. PubMed ID: 7778896 [TBL] [Abstract][Full Text] [Related]
15. Effect of sialylation of lipopolysaccharide of Neisseria gonorrhoeae on recognition and complement-mediated killing by monoclonal antibodies directed against different outer-membrane antigens. de la Paz H; Cooke SJ; Heckels JE Microbiology (Reading); 1995 Apr; 141 ( Pt 4)():913-20. PubMed ID: 7539687 [TBL] [Abstract][Full Text] [Related]
16. The serum resistance of gonococci in the majority of urethral exudates is due to sialylated lipopolysaccharide seen as a surface coat. Parsons NJ; Curry A; Fox AJ; Jones DM; Cole JA; Smith H FEMS Microbiol Lett; 1992 Jan; 69(3):295-9. PubMed ID: 1372874 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. Mandrell RE; Lesse AJ; Sugai JV; Shero M; Griffiss JM; Cole JA; Parsons NJ; Smith H; Morse SA; Apicella MA J Exp Med; 1990 May; 171(5):1649-64. PubMed ID: 1692081 [TBL] [Abstract][Full Text] [Related]
18. Lactic acid is the factor in blood cell extracts which enhances the ability of CMP-NANA to sialylate gonococcal lipopolysaccharide and induce serum resistance. Parsons NJ; Boons GJ; Ashton PR; Redfern PD; Quirk P; Gao Y; Constantinidou C; Patel J; Bramley J; Cole JA; Smith H Microb Pathog; 1996 Feb; 20(2):87-100. PubMed ID: 8722097 [TBL] [Abstract][Full Text] [Related]
19. Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated. Elkins C; Carbonetti NH; Varela VA; Stirewalt D; Klapper DG; Sparling PF Mol Microbiol; 1992 Sep; 6(18):2617-28. PubMed ID: 1280317 [TBL] [Abstract][Full Text] [Related]
20. Resistance to human serum of gonococci in urethral exudates is reduced by neuraminidase. Parsons NJ; Cole JA; Smith H Proc Biol Sci; 1990 Jul; 241(1300):3-5. PubMed ID: 1978333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]